CUTR - Cutera, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Brisbane,
United States
Type: Equity
CUTR price evolution
CUTR
| (in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $84.31 | $105.44 | $180.22 | |
| Short term investments | ||||
| Net receivables | $34.55 | $37.02 | $43.37 | $49.83 |
| Inventory | $80.35 | $94.05 | $61.73 | $61.85 |
| Total current assets | $210.98 | $235.23 | $268.33 | $311.31 |
| Long term investments | ||||
| Property, plant & equipment | $39.53 | $44 | $47.33 | $80.61 |
| Goodwill & intangible assets | $1.34 | $1.34 | $1.34 | |
| Total noncurrent assets | $65.31 | $76.77 | $95.33 | |
| Total investments | ||||
| Total assets | $276.3 | $311.99 | $355.17 | $406.63 |
| Current liabilities | ||||
| Accounts payable | $17.62 | $13.32 | $19.83 | $31.37 |
| Deferred revenue | $10.3 | $10.46 | $13.11 | |
| Short long term debt | $3.38 | $3.23 | $2.51 | |
| Total current liabilities | $60.15 | $72.7 | $84.62 | $92.41 |
| Long term debt | $420.56 | $429.31 | $418.69 | $427.6 |
| Total noncurrent liabilities | $431.81 | $431.85 | $430.31 | |
| Total debt | $432.45 | $432.54 | $430.11 | |
| Total liabilities | $491.97 | $504.56 | $515 | $522.72 |
| Shareholders' equity | ||||
| Retained earnings | -$350.81 | -$326.12 | -$291.34 | -$246.11 |
| Other shareholder equity | ||||
| Total shareholder equity | -$215.67 | -$192.56 | -$116.08 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $146.62 | $164.86 | $47.05 | |
| Short term investments | $171.39 | |||
| Net receivables | $43.37 | $45.56 | $31.45 | $21.96 |
| Inventory | $61.73 | $63.63 | $39.5 | $28.51 |
| Total current assets | $268.33 | $451.24 | $249.66 | $106.3 |
| Long term investments | ||||
| Property, plant & equipment | $47.33 | $53.2 | $17.65 | $19.38 |
| Goodwill & intangible assets | $1.34 | $1.34 | $1.34 | |
| Total noncurrent assets | $69.75 | $30.63 | $26.44 | |
| Total investments | $171.39 | |||
| Total assets | $355.17 | $520.99 | $280.29 | $132.73 |
| Current liabilities | ||||
| Accounts payable | $19.83 | $33.74 | $7.89 | $6.68 |
| Deferred revenue | $13.5 | $10.82 | $11.24 | |
| Short long term debt | $2.81 | $2.42 | $5.89 | |
| Total current liabilities | $84.62 | $105.84 | $73.9 | $54.36 |
| Long term debt | $418.69 | $416.46 | $147.73 | $19.5 |
| Total noncurrent liabilities | $430.33 | $149.82 | $21.5 | |
| Total debt | $430.62 | $150.15 | $25.39 | |
| Total liabilities | $515 | $536.17 | $223.72 | $75.85 |
| Shareholders' equity | ||||
| Retained earnings | -$291.34 | -$140.51 | -$58.17 | -$60.23 |
| Other shareholder equity | -$0.09 | |||
| Total shareholder equity | -$15.18 | $56.57 | $56.88 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $34.38 | $38.79 | $49.54 | |
| Cost of revenue | $26.73 | $26.37 | ||
| Gross Profit | $7.64 | $12.42 | $6.24 | |
| Operating activities | ||||
| Research & development | $4.46 | $5 | ||
| Selling, general & administrative | $24.98 | $36.56 | ||
| Total operating expenses | $29.45 | $31.85 | $50.56 | |
| Operating income | -$21.8 | -$19.43 | ||
| Income from continuing operations | ||||
| EBIT | -$21.74 | -$19.86 | ||
| Income tax expense | -$0.02 | -$0.03 | $0.77 | |
| Interest expense | $2.96 | $2.94 | -$1.18 | |
| Net income | ||||
| Net income | -$24.68 | -$22.78 | -$45.23 | |
| Income (for common shares) | -$24.68 | -$22.78 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $212.37 | $252.4 | $231.27 | $147.68 |
| Cost of revenue | $112.57 | $98.17 | $71.91 | |
| Gross Profit | $60.41 | $139.83 | $133.1 | $75.77 |
| Operating activities | ||||
| Research & development | $25.16 | $21.57 | $14.32 | |
| Selling, general & administrative | $152.86 | $109.71 | $84.28 | |
| Total operating expenses | $203.44 | $178.02 | $131.28 | $98.6 |
| Operating income | -$38.19 | $1.83 | -$22.83 | |
| Income from continuing operations | ||||
| EBIT | -$75.04 | $5.9 | -$23.41 | |
| Income tax expense | $1.53 | $1.64 | $1.32 | $0.47 |
| Interest expense | -$3.07 | $5.66 | $2.51 | |
| Net income | ||||
| Net income | -$150.83 | -$82.34 | $2.06 | -$23.88 |
| Income (for common shares) | -$82.34 | $2.06 | -$23.88 | |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$24.68 | -$22.78 | -$44.27 | |
| Operating activities | ||||
| Depreciation | $1.8 | $1.99 | $1.99 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.59 | $2.11 | $1.62 | |
| Total cash flows from operations | -$20.24 | -$37.63 | -$36.88 | |
| Investing activities | ||||
| Capital expenditures | -$0.88 | -$0.28 | -$5.53 | |
| Investments | $41.04 | |||
| Total cash flows from investing | -$0.88 | -$0.28 | $137.19 | $35.51 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.47 | |||
| Net borrowings | $0.01 | -$0.2 | -$0.15 | |
| Total cash flows from financing | -$0.01 | -$0.26 | -$2.57 | $0.23 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$21.13 | -$38.17 | -$3.01 | -$1.14 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$82.34 | $2.06 | -$23.88 | |
| Operating activities | ||||
| Depreciation | $2.62 | $1.34 | $1.39 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $14.4 | $13.17 | $10.11 | |
| Total cash flows from operations | -$67 | $1.24 | -$16.93 | |
| Investing activities | ||||
| Capital expenditures | -$22.7 | -$0.94 | -$1.25 | |
| Investments | -$171.48 | $7.64 | ||
| Total cash flows from investing | $137.19 | -$194.18 | -$0.94 | $6.39 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.72 | $2.77 | $30.38 | |
| Net borrowings | $302.5 | $133.07 | $6.63 | |
| Total cash flows from financing | -$2.57 | $242.94 | $117.53 | $31.28 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$3.01 | -$18.24 | $117.82 | $20.73 |
News
Fundamentals
| Market cap | $6.43M |
|---|---|
| Enterprise value | $354.57M |
| Shares outstanding | 20.11M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | -0.03 |
| Book/Share | -10.73 |
| Cash/Share | 4.19 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.51 |
| Quick ratio | 2.17 |